2018 annual financial data
Vivos Therapeutics 2018 Net margin
Direct answer
Net margin was -222.54%.
Operating income was -8,336,182 USD and net income was -8,439,156 USD.
Operating cash flow was -5,313,891 USD.
Get free Vivos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,792,261 USD
- Operating income
- -8,336,182 USD
- Net income
- -8,439,156 USD
- Operating cash flow
- -5,313,891 USD